Bill Ackman And Valeant Settle Allergan Insider Trading Lawsuit For $290 Million

Hedge funder Bill Ackman and Valeant Pharmaceuticals will pay $290 million to settle claims from shareholders in Allergan they engaged in insider trading when pressing a takeover of the botox-maker in 2014. The settlement means Valeant likely cost Pershing $4 billion.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NYSE:VRX NYSE:AGN AMS:PSH Source Type: news